Search Results - "Gökmen Sevindik, Ömür"

Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient by Özalp, Yunus Can, Shehabie, Hajrij, Tekin, Mehmet Günhan, Kaya, Süreyya Yiğit, Beköz, Hüseyin Saffet, Maral, Senem, Sevindik, Ömür Gökmen, Kaynar, Leylagül

“…Pneumocystis jirovecii pneumonia (PJP) is an opportunistic infection that primarily affects immunocompromised individuals. Typical symptoms of PJP include the…”
Get full text

Persistent Polyclonal B-Cell Lymphocytosis with Binucleated Lymphocytes by Balık Aydın, Berrin, Mutlu, Yaşa Gül, Sevindik, Ömür Gökmen

Get full text

Should Core Needle Lymph Node Biopsy be a Relevant Alternative to Surgical Excisional Biopsy in Diagnostic Work Up of Lymphomas? by Mutlu, Yaşa Gül, Balık Aydın, Berrin, Çakır, Aslı, Canöz, Özlem, Erol, Cengiz, Gökmen Sevindik, Ömür

“…Surgical excisional biopsy is accepted as the standard of care approach in the diagnosis of lympho- mas. Financial issues related to the increased cost and the…”
Get full text

Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder by Yiğit Kaya, Süreyya, Askin, Abdullah Emre, Bektas, Sebnem, Çakır, Aslı, Gökmen Sevindik, Ömür

“…•Acute myeloid leukemia•Post transplant lymphoproliferative disorder•Epstein-Barr virus Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains…”
Get full text

Prognostic Factors in Elderly Patients With Diffuse Large B-Cell Lymphoma and Their Treatment Results by Adıyaman, Süleyman Cem, Alacacioğlu, İnci, Danyeli, Ayça Ersen, Türkyılmaz, Doğuş, Sevindik, Ömür Gökmen, Demirkan, Fatih, Pişkin, Özden, Özcan, Mehmet Ali, Ündar, Bülent, Özkal, Şermin, Özsan, Güner Hayri

“…Objective: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). The treatment of older NHL patients has always been a…”
Get full text

Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment? by Solmaz Medeni, Şerife, Türkyılmaz, Doğuş, Acar, Celal, Sevindik, Ömür Gökmen, Yüksel, Faize, Pişkin, Özden, Özcan, Mehmet Ali, Demirkan, Fatih, Ündar, Bülent, Alacacıoğlu, İnci, Özsan, Güner Hayri

“…High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A…”
Get full text

Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study by Çiftçiler, Rafiye, Sevindik, Ömür Gökmen, Tekgündüz, Ali İrfan Emre, Erkurt, Mehmet Ali, Vural, Filiz, Turgut, Burhan, Kaynar, Leylagül, Payzın, Bahriye, Doğu, Mehmet Hilmi, Karakuş, Volkan, Altuntaş, Fevzi, Büyükaşık, Yahya, Demirkan, Fatih

“…Significant developments occurred in the clinical management of acute lymphoblastic leukemia (ALL) in adults in recent decades. However, treatment results are…”
Get full text

Nilotinib Does Not Alter the Secretory Functions of Carotid Artery Endothelial Cells in a Prothrombotic or Antithrombotic Fashion by Katgı, Abdullah, Sevindik, Ömür Gökmen, Gökbulut, Aysun Adan, Özsan, Güner Hayri, Yüksel, Faize, Solmaz, Şerife Medeni, Alacacıoğlu, İnci, Özcan, Mehmet Ali, Demirkan, Fatih, Baran, Yusuf, Pişkin, Özden

“…There have been concerns about the possible prothrombotic effects of nilotinib, especially in patients having cardiovascular risk factors. The potential…”
Get more information

Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases by Akkus, Erman, Tuncalı, Timur, Akın, Hasan Yalım, Aydın, Yıldız, Beşışık, Sevgi Kalayoğlu, Gürkan, Emel, Ratip, Siret, Salihoğlu, Ayşe, Sargın, Deniz, Ünal, Ali, Turcan, Ayşegül, Sevindik, Ömür Gökmen, Demir, Muzaffer, Beksac, Meral

“…Multiple myeloma (MM) is a haematological malignancy primarily affecting the elderly, with a striking male predilection and ethnic disparities in incidence…”
Get full text

Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience by Özdemirkıran, Füsun, Payzın, Bahriye, Kiper, H Demet, Kabukçu, Sibel, Akgün Çağlıyan, Gülsüm, Kahraman, Selda, Sevindik, Ömür Gökmen, Ceylan, Cengiz, Kadıköylü, Gürhan, Şahin, Fahri, Keskin, Ali, Arslan, Öykü, Özcan, Mehmet Ali, Kabukçu, Gülnur, Görgün, Gülsüm, Bolaman, Zahit, Büyükkeçeci, Filiz, Bilgir, Oktay, Alacacıoğlu, İnci, Vural, Filiz, Tombuloğlu, Murat, Gökgöz, Zafer, Saydam, Güray

“…Immune thrombocytopenia (ITP) is an immune-mediated disease characterized by transient or persistent decrease of the platelet count to less than 100x109/L…”
Get full text

Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation by Özsan, Güner Hayri, Ündar, Bülent, Özcan, Mehmet Ali, Pişkin, Özden, Acar, Celal, Solmaz, Şerife Medeni, Katgı, Abdullah, Alacacıoğlu, İnci, Sevindik, Ömür Gökmen, Demirkan, Fatih

“…Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenge after allogeneic hematopoietic progenitor cell transplantation, considering the…”
Get full text

PB1897: GILTERITINIB IN TURKEY: EARLY ACCESS PROGRAM RESULTS by Dogu, Mehmet Hilmi, Tekgunduz, Ali Irfan Emre, Deveci, Burak, Korkmaz, Gulten, Comert, Melda, Sevindik, Ömür Gökmen, Yokus, Osman, Serin, Istemi

Get full text

A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma by Gemici, Aliihsan, Bilgen, Hülya, Erdoğan, Cem, Kansu, Abdullah, Olmuşçelik, Oktay, Beköz, Hüseyin Saffet, Çakmak, Rumeysa, Mert, Ali, Sevindik, Ömür Gökmen

“…A SARS-Cov2 infection which was first arised from Wuhan in December 2019 and named as COVID-19. Still there lacks either a specific treatment or a vaccine to…”
Get full text

A Case of Severe Plasmodium falciparum Malaria Co-Infected with HIV Improved with Exchange Transfusion by Sağmak Tartar, Ayşe, Akbulut, Ayhan, Gökmen Sevindik, Ömür, Akbulut, Hatice Handan, Demirdağ, Kutbeddin

“…In our country, within years, despite a dramatic drop in the number of patients with malaria, a dramatic increase in the number of patients with import malaria…”
Get full text

Artificial Intelligence to Assist Better Myeloma Care, is It the Time? by Sevindik, Ömür Gökmen

Get full text

Successful use of split-dose intravenous daratumumab in a multiple myeloma patient after a first-dose life-threatening infusion-related reaction by Aykaş, Fatma, Karakuş, Volkan, Sevindik, Ömür Gökmen

“…Introduction Daratumumab is a humanized IgG1 kappa monoclonal antibody directed against CD38 used to treat myeloma. The recommended dose of daratumumab is 16…”
Get full text

CLL-395: Real-World Data from the Turkish National Chronic Lymphocytic Leukemia Registry by Demirkan, Fatih, Sevindik, Ömür Gökmen

“…We have previously established a nationwide registry to obtain real-world data to document the demographics and treatment outcomes of Turkish CLL patients…”
Get full text

BELLWAVE-008: A phase 3 study of the efficacy and safety of nemtabrutinib in previously untreated patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) without TP53 aberrations by Sevindik, Ömür Gökmen, Chen, Chang, Yang, Jing, Farooqui, Mohammed Z.H., Paszkiewicz-Kozik, Ewa

“…TPS7594 Background: Targeting the Bruton’s tyrosine kinase (BTK) pathway has been a revolutionary treatment option for first-line treatment of CLL/SLL…”
Get full text

KEYFORM-008: Coformulated favezelimab and pembrolizumab (MK4280A) versus chemotherapy in relapsed/refractory classical Hodgkin lymphoma by Lavie, David, Timmerman, John, Garcia Sanz, Ramón, Kim, Won Seog, Kim, Tae Min, Avigdor, Abraham, Dierickx, Daan, Jagadeesh, Deepa, Molin, Daniel, Ozcan, Muhit, Sevindik, Ömür Gökmen, Saeed, Hayder, Sidi, Yulia, Pillai, Pallavi, Marinello, Patricia, Herrera, Alex Francisco

“…TPS7585 Background: PD-1 inhibitors are highly effective in patients (pts) with relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL), but treatment…”
Get full text

Zilovertamab vedotin (MK 2140) in relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Early results from the phase 2 waveLINE-004 study by Ozcan, Muhit, Lee, Seung Tae, Mensah, Felix, Modi, Dipenkumar, Fossa, Alexander, Seog Kim, Won, Paszkiewicz-Kozik, Ewa, Sawalha, Yazeed, Sevindik, Ömür Gökmen, Norasetthada, Lalita, Santoro, Armando, Pathiraja, Kumudu, Chakraborty, Samhita, Marinello, Patricia, Lavie, David

“…7531 Background: Treatment options are limited for patients (pts) with R/R DLBCL who are not candidates for autologous stem cell transplant (ASCT). ROR1 is an…”
Get full text